Bristol-Myers Squibb Company (NYSE:BMY) is included among the Best Low Risk Stocks for a Retirement Stock Portfolio. Janux Therapeutics Partners With Bristol-Myers (BMY) on Solid Tumor Therapy Janux Therapeutics said on January 22 that it has partnered with Bristol-Myers Squibb Company (NYSE:BMY) to develop a new cancer treatment, according to Reuters. The announcement was well received by the market, with Janux shares jumping more than 12% in premarket trading. The therapy is aimed at solid tumors, canc ...